Provided by Tiger Trade Technology Pte. Ltd.

Amgen

442.24
-1.6000-0.36%
Post-market: 443.000.7600+0.17%19:59 EDT
Volume:2.10M
Turnover:932.33M
Market Cap:238.14B
PE:27.47
High:447.03
Open:443.26
Low:441.26
Close:443.84
52wk High:447.03
52wk Low:269.77
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.83
T/O Rate:0.39%
Dividend:9.80
Dividend Rate:2.22%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:20.37
PE(LYR):31.08

Loading ...

KalÉO Announces License Agreement with Amgen for Auto-Injector Technology

THOMSON REUTERS
·
Aug 03

KalÉO: Financial and Other Terms of Agreement were not Disclosed

THOMSON REUTERS
·
Aug 03

Sino Biopharmaceutical Stock Falls 1.7% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 03

Amgen Finds No Material Impact From Cybersecurity Incident

MT Newswires Live
·
Aug 01

Amgen Says Proprietary Data, Patient Health Info were Exfiltrated in Cyber Incident

Dow Jones
·
Aug 01

Amgen Discloses Data Breach, Says Patient Information was Stolen

Reuters
·
Aug 01

Amgen says cybersecurity incident not likely to have material impact

TIPRANKS
·
Aug 01

Amgen - Determines Cybersecurity Incident is Material as of July 29, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 01

Amgen - Identifies Unauthorized Activity in Third-Party Cloud Environments in July 2026 - SEC Filing

THOMSON REUTERS
·
Aug 01

Amgen - Reports Exfiltration of Proprietary and Patient Data from Cloud Environments - SEC Filing

THOMSON REUTERS
·
Aug 01

Amgen - Reports no Impact to Products, Operations, or Financial Reporting from Incident - SEC Filing

THOMSON REUTERS
·
Aug 01

How Investors May Respond To Amgen (AMGN) Repatha Expansion and 2026 Dividend Declaration

Simply Wall St.
·
Jul 31

RBC Capital Remains a Buy on Amgen (AMGN)

TIPRANKS
·
Jul 31

Amgen Keeps Quarterly Dividend at $2.52 a Share, Payable Sept. 11 to Holders of Record Aug. 21

MT Newswires Live
·
Jul 31

Amgen Declares USD 2.52/share Q3 2026 Dividend

Reuters
·
Jul 31

Amgen Announces 2026 Third Quarter Dividend

THOMSON REUTERS
·
Jul 31

Press Release: AMGEN Announces 2026 THIRD Quarter Dividend

Dow Jones
·
Jul 31

Amgen Halts Key Bemarituzumab Gastric Cancer Trial, Narrowing Near-Term Upside for AMGN

TIPRANKS
·
Jul 30

Amgen Says EU CHMP Backs Broader Repatha Use to Cut First Heart Attack, Stroke Risk

Reuters
·
Jul 29

Amgen - Chmp Adopts Positive Opinion for Amgen's Repatha (Evolocumab)

THOMSON REUTERS
·
Jul 29